Soundarya Palanisamy
Sr. Pre-Sales Solutions Architect - EMEA & AP Health and Life Sciences CxP

Soundarya Palanisamy is an Industry Advisor based in Germany and is part of the Health and Life Sciences Practice at SAS. She supports clients by providing guidance on their journey of digital transformation through the usage of AI, analytics and technology. She specializes in machine learning, text mining and analytical life cycle management enabling her to unlock insights that optimize processes and spearhead innovation in the healthcare and life sciences domains. From her previous experience, she possesses a profound understanding of regulatory data science.

Advanced Analytics | Analytics
Soundarya Palanisamy 0
Decentralizing clinical trials: how COVID-19 has changed drug development

The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.